businesspress24.com - Merus to Present at 15th Annual Rodman & Renshaw Investment Conference
 

Merus to Present at 15th Annual Rodman & Renshaw Investment Conference

ID: 1260233

(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 09/03/13 -- Merus Labs International Inc. ("Merus"or the "Company") (TSX: MSL) (NASDAQ: MSLI) today announced that Mr. Elie Farah, the President & CEO of Merus, will present at the upcoming 15th Annual Rodman & Renshaw Global Investment Conference. The conference, sponsored by H.C. Wainwright & Co., LLC, is being held September 8-10, 2013. Mr. Farah's presentation will take place on Monday, September 9th, 2013 at 12:30 P.M. (Eastern Time) in Room 7.01 (7th floor); Millennium Broadway Hotel in New York City.

About Merus Labs International Inc.

Merus is a specialty pharmaceutical company engaged in the acquisition and licensing of pharmaceutical products. The Company utilizes its expertise in pharmaceutical markets and its access to capital to acquire and license niche branded products. Merus further enhances the sale and distribution of these products by the introduction of a focused marketing and promotion plan.

Cautionary Statement

Certain statements contained in this press release may constitute "forward-looking statements" within the meaning of Section 21E (i) (1) of the United States Securities Exchange Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Merus' actual results to be materially different from any future results expressed or implied by these statements. Such factors include the following: general economic and business conditions, changes in demand for Merus' products, changes in competition, the ability of Merus to integrate acquisitions or complete future acquisitions, interest rate fluctuations, currency exchange rate fluctuations, dependence upon and availability of qualified personnel and changes in government regulation. In light of these and other uncertainties, the forward-looking statements included in this press release should not be regarded as a representation by Merus that Merus' plans and objectives will be achieved. These forward-looking statements speak only as of the date of this press release, and we undertake no obligation to update or revise the statements.







Contacts:
Merus Labs International Inc.
Elie Farah
President and CEO
(416) 593-3701


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Diabetic Patients at High Risk for Aortic Valve Surgery Experienced Lower All-Cause Mortality When Treated With SAPIEN Valve
biOasis to Present at the 2013 Gateway Conference on September 10
Bereitgestellt von Benutzer: Marketwired
Datum: 03.09.2013 - 14:00 Uhr
Sprache: Deutsch
News-ID 1260233
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

TORONTO, ONTARIO


Phone:

Kategorie:

Medical Devices


Anmerkungen:


Diese Pressemitteilung wurde bisher 84 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Merus to Present at 15th Annual Rodman & Renshaw Investment Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von

Merus Labs International Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Merus Labs International Inc.



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 150


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.